Leveraging Technology to Improve Epilepsy Treatment: Responsive Neurostimulation
An update on responsive neurostimulation, the only implantable, closed-loop device approved for treating seizures.
A Quiz on SUDEP
3 things you may not know—from the new AAN guidelines—about sudden unexpected death in epilepsy.
Responsive Neurostimulation: 5 Important Facts
Key details about an option for the treatment of drug-resistant epilepsy in patients who are not surgical candidates.
The Human Epilepsy Project
Dr. Loeb summarizes a global and one-of-a-kind approach of biomarker and drug discovery using systems biology of human brain tissues.
Noninvasive Biomarkers for Epilepsy: A New Way Forward
Thanks to technology, it may be possible to diagnose epilepsy in patients earlier and via noninvasive means.
Anti-epileptics in Pregnancy?
What are the risks of anti-seizure meds in pregnancy? Benefits?
AAN SUDEP Guidelines: A Quiz
Here: 3 questions that challenge your acumen about the latest AAN guidelines on sudden unexplained death in epilepsy.
Pregnancy Outcomes with Pregabalin Use
In this Medical News Minute, Dr. Bobby Lazzara highlights possible birth defects resulting from women taking pregabalin during pregnancy.
Modeling Simulations to Predict AED Efficacy
Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).
Potential Treatment for SRSE
Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.
Antiepileptic Drug Choice: Patient vs Neurologist
Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.
Neurology in the News: Migraine, Childhood Epilepsy, and More
New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.
New Insights About Accelerated Long-Term Forgetting in Epilepsy
Here’s evidence that ALF may be an important memory disorder in subgroups of patients with epilepsy.
By clicking Accept, you agree to become a member of the UBM Medica Community.